Navigation Links
Neuralstem Updates ALS Stem Cell Trial Progress
Date:5/8/2012

ROCKVILLE, Md., May 8, 2012 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that the Federal Drug Administration (FDA) has approved the return of three patients from earlier cohorts in its ongoing Phase I safety trial to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) with its spinal cord stem cells (HSSC's). These patients will be permitted to return to the trial for second treatments as the next cohort of patients, provided they meet inclusion requirements at the scheduled time. They will be the first to receive stem cell transplantation along the length of the spinal cord.

(Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO )

The first twelve patients in the trial, which is taking place at Emory University Hospital in Atlanta, Georgia, received stem cell transplants in the lumbar (lower back) region of the spinal cord only. The last cohort of three, completed in April, received transplants in the cervical (upper back) region of the spinal cord, where stem cell transplantation could help support breathing, a key function that is lost as ALS progresses. The next cohort of three patients is designed to receive 10 HSSC injections in the lumbar region and 5 in the cervical, for a total of 15 injections along the length of the spinal cord.  In the case of the returning patients, who have already received 10 lumbar injections, they will receive five cervical injections. These patients are between 15-17 months out from their first dosing and appear to have tolerated the first procedure well.

Additionally, Neuralstem has submitted a trial amendment to the FDA to increase both the number of patients treated as well as the dose in future cohorts. The amendment would also expand the trial to include certain efficacy endpoints. The trial was initiall
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Neuralstem Announces Issuance of Core Technology Patent in Europe
2. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
3. Neuralstems ALS Trial on Clinical Hold
4. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
5. Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
6. Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
7. Neuralstem Updates ALS Clinical Trial Progress
8. Dr. Eva Feldman, Principal Investigator, Presents Interim Safety Results for Neuralstem ALS Trial
9. Neuralstem Updates NSI-189 Major Depression Trial
10. Neuralstem Announces Notice of Allowance for Two Additional Neurogenic Compound Patents
11. Dr. Eva Feldman, Principal Investigator, Presents Interim Data on Neuralstem ALS Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015  The investigational S- ... alleviate certain menopause symptoms, such as hot flashes, according ... Journal of Women,s Health .[i] "Current data ... equol for menopausal vasomotor symptoms and possibly additional benefits, ... of S- equol, physicians and health care professionals ...
(Date:3/30/2015)... March 30, 2015  A promising University of Michigan ... with a rare and lethal subtype of leukemia has ... with a new biotechnology company, Kura Oncology.  The Leukemia ... led by Assistant Professor Jolanta Grembecka , Ph.D, ... the University of Michigan, since 2009. ...
(Date:3/30/2015)... MINNEAPOLIS and ORANGEBURG, N.Y., March 30, 2015 ... Inc. (NASDAQ: VSCI ) shareholders have voted ... held today to approve the previously announced agreement ... "We are pleased with the outcome ... to thank both shareholder groups for approving the ...
Breaking Medicine Technology:New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 2New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 3New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 4New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 5New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 6Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 2Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 2Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 4
(Date:3/30/2015)... Dr. Shahdad Arami is now offering ... $200 off their Invisalign treatment. Many people crave straighter ... mouthful of metal. Invisalign offers an alternative. According to ... effective for straightening teeth but has no aesthetic value ... appearance. The Invisalign system allows both teenagers and adults ...
(Date:3/30/2015)... On March 27th, 2015, 24Hr HomeCare ... inspire courage in Seth Lane, a five-year-old boy from ... SCID causes affected individuals to be susceptible to life-threatening ... allow the development of functional immune systems. Lane, ... video with his family requesting its viewers to wear ...
(Date:3/30/2015)... V/NO (Virtually No Alcohol) Wines have a sleek single-serve ... for reuse. Consumers simply twist the cup, turn it upward ... and basically anyone can now enjoy a non-alcoholic wine ... or pair with meals at work, home, or wherever the ... and that means Napa Wine grapes undergo the traditional wine ...
(Date:3/30/2015)... 2015 Software applications from five ... the second AS4 test and certification event, announced ... in interoperability software testing. New software applications from ... participated in this vendor-neutral test event which began ... interoperability certifications for IBM, Oracle and Software AG, ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Corra Group is ... accommodate the needs of every industry that requires this form ... compliance mandates or seek new ways to increase productivity and ... drug panels that will help detect substance abuse with a ... mandated drug tests,” said Corra Group Co-Founder, Gordon Basichis. ...
Breaking Medicine News(10 mins):Health News:Northridge Cosmetic Dentist, Dr. Arami, is Now Offering a New Promotion on Invisalign 2Health News:24Hr HomeCare Staff Hosts #WearYellowForSeth Campaign for Five-Year-Old Boy with Severe Combined Immunodeficiency 2Health News:Napa Valley Alcohol-Removed Red, White & Rosé Wines Have Launched. 2Health News:Latest AS4 Standard-Based Products Drummond Certified™ 2Health News:Latest AS4 Standard-Based Products Drummond Certified™ 3Health News:Corra Group Adds New Employment Screening Drug Test Solutions for Clients in Every Industry 2Health News:Corra Group Adds New Employment Screening Drug Test Solutions for Clients in Every Industry 3
... WASHINGTON, Sept. 24 Benjamin England,Special Counsel with ... Rural Development, Food and Drug Administration, and Related,Agencies, ... September,25, 2007 at 10:00 a.m. in Room 2362A ... focus on the on the Food & Drug ...
... advances in diabetes care, African Americans and Latinos are ... blood sugar under control, even with the help of ... them at a much higher risk of blindness, heart ... complications. , The comprehensive new national study of ...
... of the,House Nancy Pelosi (D-CA) and Representatives ... introduced the Coordinated Environmental,Public Health Network Act ... public health tracking network to allow for ... adverse health effects and,environmental hazards, and increase ...
... host more than 200 physicians and emergency medicine technicians ... Conference, Sept. 26-28. Those attending will learn how to ... circumstances encountered in the wilderness., The emergency medical system ... New York City and the 2005 Hurricane Katrina disaster ...
... being,issued by Rosa Acuna and Harold J. Cassidy: WHAT: Filing ... Jersey Supreme Court as last ... in the historic informed consent abortion,case will be filing a motion ... Jersey Supreme Court in which that court held,that a physician can ...
... More than 1 million consumers impacted by information to make ... ... Sept. 24 Massachusetts employers and health,plans have successfully completed ... Excellence (BTE) programs, the nation,s,largest effort to reward physicians for ...
Cached Medicine News:Health News:Benjamin England, Former FDA Regulatory Counsel, to Testify on FDA Import Strategic Plan Before House Appropriations Subcommittee 2Health News:Older blacks and Latinos still lag whites in controlling diabetes 2Health News:Older blacks and Latinos still lag whites in controlling diabetes 3Health News:Older blacks and Latinos still lag whites in controlling diabetes 4Health News:Older blacks and Latinos still lag whites in controlling diabetes 5Health News:Pelosi, Slaughter and Tubbs Jones Introduce Health Tracking Legislation 2Health News:Filing for Reconsideration/Press Conference ACUNA v. TURKISH, Historic Informed Consent Abortion Case to the New Jersey Supreme Court 2Health News:Massachusetts Employers and Health Plans Continue to Support Quality Care by Rewarding Physicians through Bridges to Excellence Programs 2Health News:Massachusetts Employers and Health Plans Continue to Support Quality Care by Rewarding Physicians through Bridges to Excellence Programs 3